Procter & Gamble Health (NSE:PGHL) Net Income From Continuing Operations : ₹2,685 Mil (TTM As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Procter & Gamble Health Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Procter & Gamble Health's net income from continuing operations for the three months ended in Mar. 2025 was ₹785 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2,685 Mil.

Procter & Gamble Health Net Income From Continuing Operations Historical Data

The historical data trend for Procter & Gamble Health's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Net Income From Continuing Operations Chart

Procter & Gamble Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Jun21

Jun22

Jun23

Jun24

Net Income From Continuing Operations

Get a 7-Day Free Trial

11,375.70

2,332.80

2,533.70

3,142.00

2,733.20

Procter & Gamble Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															465.60	167.80	823.30	909.00	785.30

Procter & Gamble Health Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,685 Mil.

Procter & Gamble Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (NSE:PGHL) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

500126:India

Address

Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099

Website

https://www.pghealthindia.com

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines

No Headlines